N@N

Market Maker Surveillance Report. STEM, PPHM, GY, IBIO, GEOY, SPRD, Winning Stocks With Lowest Price Friction For Monday, July

July 23, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 3873 companies with "abnormal" market making, 1314 companies with positive Friction Factors and 4218 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Monday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. StemCells Inc (NASDAQ:STEM), Peregrine Pharmaceuticals Inc (NASDAQ:PPHM), GenCorp Inc (NYSE:GY), Ibio Inc (AMEX:IBIO), GeoEye Inc (NASDAQ:GEOY), Spreadtrum Communications Inc (NASDAQ:SPRD). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  STEM    $0.280    18.06%    6,516,978    54.80%    5,346,223    44.96%    1,170,755    41,813  
  PPHM    $0.460    35.41%    4,926,031    54.72%    4,067,160    45.18%    858,871      18,671  
  GY      $0.830    12.30%    1,176,087    45.30%    579,839      22.34%    596,248      7,184   
  IBIO    $0.200    21.74%    95,865       27.52%    72,107       20.70%    23,758       1,188   
  GEOY    $5.020    33.09%    1,622,330    54.30%    1,328,862    44.48%    293,468      585     
  SPRD    $2.890    16.71%    577,442      53.85%    491,754      45.86%    85,688       296     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows STEM with a dollar gain Monday of $0.28000 and a Friction Factor of 41,813 shares. That means that it only took 41,813 more shares of buying than selling to move STEM higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

StemCells Inc (NASDAQ:STEM) - StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of stem cell therapeutics and related technologies. It develops cell-based therapeutics for the central nervous system and liver. The companys lead product candidate, HuCNS-SC cells have completed a Phase I clinical trial for the treatment of infantile and late infantile neuronal ceroid lipofuscinosis, a neurodegenerative disease that affects infants and young children. HuCNS-SC cells are also in Phase I clinical trial for the treatment of Pelizeaus-Merzbacher disease, a fatal myelination disorder in the brain. In addition, it involves in preclinical development with its human liver engrafting cells (hLEC) to evaluate hLEC as a potential cellular therapy for a range of liver diseases. Further, the company is developing and commercializing applications of its technologies to enable stem cell-based research to academic and industrial laboratories. It markets a range of proprietary cell culture products under the SC Proven brand, including iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff N2B27, NDiff 2 and 27 supplements, HEScGRO, and ESGRO Complete proprietary media. StemCells, Inc. has exclusive rights to approximately 50 issued or allowed U.S. patents, and 200 granted or allowed non-U.S. patents. The company was founded in 1988 and is based in Palo Alto, California.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM) - Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development and manufacture of monoclonal antibodies for the treatment of cancer and viral infections. The company develops clinical programs with its novel compounds bavituximab and Cotara, which are the clinical candidates under its anti-phosphatidylserine therapeutics and tumor necrosis therapy platforms. Its pipeline products comprise Bavituximab Plus Docetaxel, and Bavituximab plus carboplatin and paclitaxel, which are Phase II clinical trial products for treating advanced breast cancer patients; and Bavituximab plus carboplatin and paclitaxel, a Phase II clinical trial product for the treatment of non-small cell lung cancer, as well as Bavituximab, which is in Phase I monotherapy repeat dose safety study for treating solid tumor cancers, and in Phase Ib repeat dose safety study for the treatment of chronic hepatitis C virus infection co-infected with HIV. In addition, its pipeline products include Cotara, a product in Phase II, as well as a dosimetry and dose confirmation study for the treatment of glioblastoma multiforme, an aggressive form of brain cancer. Further, Peregrine, through its wholly owned subsidiary, Avid Bioservices, Inc., provides contract manufacturing services for biotechnology and biopharmaceutical companies, from pre-clinical drug supplies up through commercial-scale drug manufacture. Further, it provides services in support of Peregrine's product pipeline, including manufacture and scale-up of pre-clinical and clinical drug supplies. The company was founded in 1981 and is based in Tustin, California.

GenCorp Inc (NYSE:GY) - GenCorp Inc. manufactures aerospace and defense products and systems in the United States. It operates in two segments, Aerospace and Defense, and Real Estate. The Aerospace and Defense segment develops and manufactures defense systems, which include liquid, solid, and air-breathing propulsion systems and components used in strategic strike missiles, tactical and precision strike missiles, missile defense systems, maneuvering propulsion systems, precision war fighting systems, and specialty metal products; and supplies composite and metallic aerospace structural components, fire suppression systems, and armament systems. It also offers space systems products comprising liquid, solid, and electric propulsion systems used in expendable and reusable launch vehicles, transatmospheric vehicles and spacecraft, separation and maneuvering systems, upper stage engines, satellites, large solid boosters, and integrated propulsion subsystems. This segments customers include prime contractors to the U.S. government, the Department of Defense, and the National Aeronautics and Space Administration. The Real Estate segment engages in the re-zoning, entitlement, sale, and leasing of the companys excess real estate assets. It owns approximately 12,200 acres of land in the Sacramento metropolitan area, California. The company was founded in 1915 and is headquartered in Rancho Cordova, California.

Ibio Inc (AMEX:IBIO) - iBio, Inc., a biopharmaceutical company, focuses on the development of vaccines and therapeutic proteins based upon its proprietary plant-based iBioLaunch Platform Technology. The company principally focuses on advancing a H1N1 influenza vaccine candidate to clinical trials and to establish business arrangements for use of the technology by licensees for the development and production of other products for the prevention and treatment of various infectious diseases, including influenza, anthrax, and human papilloma virus. iBio holds a research and development agreement with the Fraunhofer USA Center for Molecular Biotechnology and has exclusive rights to the proprietary platform developed under the agreement for human health applications for developing vaccines and therapeutic products for a broad range of medical indications and for veterinary applications of plant-based influenza vaccines. The company was formerly known as iBioPharma, Inc. and changed its name to iBio, Inc. in August 2009. iBio is headquartered in Newark, Delaware.

GeoEye Inc (NASDAQ:GEOY) - GeoEye, Inc., together with its subsidiaries, provides earth imagery and imagery information products, as well as image processing services to the United States and foreign government defense and intelligence organizations, domestic federal and foreign civil agencies, and commercial customers. The company owns and operates three earth-imaging satellites, which include GeoEye-1, IKONOS, and Orbview-2; and three fixed-wing aircraft with high-resolution imagery collection capabilities. The GeoEye-1 and IKONOS satellites principal applications include national security, mapping, oil and gas, infrastructure, mining, land use, and land planning; and Orbview-2 satellites applications primarily comprise weather, fishing, agriculture, scientific research, and environmental monitoring. The companys satellite imagery products include Geo, GeoProfessional, and GeoStereo that provide the customers with time-critical visual imagery, data, and information. Its aerial imaging products consist of digital aerial imaging and light detection and ranging imaging (LiDAR). The companys production services range from the generation of precision imagery products to the extraction of site-specific features for the companys customers database development. These production services include Georectification, Image Mosaicing, Tonal Correction, and Orthorectification; and LiDAR elevation data, maps, topographic maps, digital orthophoto imagery, remote sensing services, survey and inventory services, and geospatial information service consulting and implementation. It sells its products directly to end users or through resellers. GeoEye, Inc. is based in Dulles, Virginia.

Spreadtrum Communications Inc (NASDAQ:SPRD) - Spreadtrum Communications, Inc., a fabless semiconductor company, designs, develops, and markets baseband processors, radio frequency (RF) transceivers, and turnkey solutions for the wireless communications and mobile television markets. It offers a portfolio of integrated baseband processor solutions that support a range of wireless communications standards, including global system for mobile communications, general packet radio service, and time division synchronous code division multiple access, a 3G standard for wireless communications. The companys solutions also provide various multimedia capabilities, such as TV-out, MP3 digital audio playback, touch screen, JAVA accelerators, digital camera support up to 5 mega-pixels, Motion JPEG, MPEG4, AVS and H.264 digital video playback, and 64-channel polyphonic ringtone playback. In addition, it designs, develops, and markets RF transceivers; and a CMMB-based channel demodulator and audio/video decoder processor solution for the mobile television market, as well as AVS audio/video decoder processor solutions for the Internet protocol television, satellite, cable, and terrestrial digital television markets. Further, the company provides turnkey solutions, including total reference design solutions, which combine its baseband semiconductors, RF transceivers, and reference designs. It sells its products directly to brand manufacturers, independent design houses, and original design manufacturers primarily in the Peoples Republic of China, Hong Kong, and Macau. The company was founded in 2001 and is headquartered in Shanghai, the Peoples Republic of China.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net

Contributing Sources

---